Pharma-Q Adrenaline 1 mg/ml INJECTION
PDF Leaflet Revision Date: 13 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of acute allergy and anaphylactic shock.
Dosage (summary)
Adults: 0.2 to 0.5 ml; Children: 0.1 to 0.3 ml.
Onset of Action / Duration
Onset: rapid, Duration: 1-2 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Use only if benefits justify risks; avoid breastfeeding.
Key Drug Interactions
- Monoamine oxidase inhibitors
- Beta-blockers
- Tricyclic antidepressants
Contraindications
- Hypersensitivity to sympathomimetics
- Ischaemic tissue necrosis risk
Common side effects
- Palpitations
- Tachycardia
- Anxiety
Counselling Points
- Monitor for adverse reactions
- Avoid use in certain areas to prevent necrosis
- Seek immediate medical attention for severe side effects
Serious warnings
- Risk of tissue necrosis with improper injection
- Caution in patients with cardiovascular disease
Important Disclaimer
The Pharma-Q Adrenaline 1 mg/ml INJECTION professional information leaflet below is the property of Pharma-Q Holdings and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
